The second generation of Wnt inhibitors: FZD5-selective inhibitors to treat cancer

Forschungsstelle

INNOSUISSE

Projektnummer

105.987 IP-LS

Projekttitel

The second generation of Wnt inhibitors: FZD5-selective inhibitors to treat cancer

Projekttitel Englisch

The second generation of Wnt inhibitors: FZD5-selective inhibitors to treat cancer

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Pharmaceuticals
Abstract (Englisch)	We have identified selective and unique FZD5 inhibitors that have the potential to become best-in-class. The purpose of this project is to support drug discovery to identify a lead compound with appropriate pharmacokinetics and in vivo efficacy in a TNBC rodent model.